Pharma Pricing and Market Access Consulting
Our broad therapeutic expertise and institutional knowledge of key access decision makers and influencers help us develop unparalleled insights to inform our clients’ pharma commercial strategy.
250+ Payer stakeholder interviews conducted last year
100+ Accessible payer organizations across the U.S. and E.U.
40% Consulting engagements with payer analysis
Project Types
Data-Driven Pricing & Market Access Solutions
Pricing Strategy
- Pricing & Contracting Strategy
- GTN Forecasting & Management, including Account- and Channel-specific Forecasts
- Revenue Preservation Strategies(e.g., authorized generics, NDC switches)
- Lifecycle Management Strategies(e.g., conversion, biosimilar defense)
- Patient Support, including Benchmarking, Design, & Modeling
Market Access Strategy
- Landscape Research & Scenario Planning
- Stakeholder Mapping & Funding Flow Analysis
- Launch Strategy
- Channel-Specific Access Strategies
- Key Account Management, Profiling, and Segmentation
- Patient Journey & Segmentation
- Model Policy
- Pre-Approval Information Exchange (PIE)
Value Strategy
- Evidence Generation Benchmarking & Strategy Development
- New Product Planning Strategy
- Value Proposition Development & Testing
- TPP Development & Testing
- Payer / Provider Engagement & Value Communication Strategy
- Practice Economics Analysis
- Budget Impact & Claims Analysis
Approach to Commercialization Assessments and Building Market Awareness
Pricing & Contracting Strategy
Objective
Develop ex-US pricing strategy for durable treatment based on need for value-based contracts
Approach
Identify payer value proposition by segment based on HEOR value
Define range of reimbursement scenarios
Develop and assess range of potential value-based contracts
Understand payer preferences regarding the need for and interest in value-based contracts
Commercial Assessment & Planning
Objective
Evaluate the value and preferences that payers have for different features of biosimilar products
Approach
Hypothesize potential payer “archetypes” that align with varying payer value propositions
Conduct virtual ad-boards and tele-depth interviews to pressure-test value propositions for payers
Explore payer willingness to partner with manufacturers to implement cost savings
Outline the payer “archetypes” that align with biosimilars
Pricing & Market Access
How does Triangle Insights Group help develop pricing strategies for new therapies?
We create pricing strategies that reflect product value, competitive landscape, and payer expectations. Our approach ensures pricing decisions support both market access and long-term sustainability, balancing commercial goals with evidence and reimbursement realities.
As part of Valeris Data and Insights, we collaborate closely with Policy Reporter to incorporate real-time policy and reimbursement intelligence, ensuring pricing strategies are informed by the latest regulatory and payer developments.
How do you assess payer perspectives and access barriers early?
We combine payer research, market insights, and stakeholder interviews to identify potential obstacles to coverage and adoption. Early understanding of these dynamics allows our clients to shape evidence, value messaging, and launch plans proactively. With deep insights into payer dynamics (and over 250 payer interviews conducted last year alone), we can offer our clients a timely and in-depth understanding.
Can you help quantify the commercial impact of different pricing or access scenarios?
Yes. We model alternative pricing, formulary, and access pathways to estimate uptake, revenue, and net value. These scenario analyses enable leadership teams to make informed decisions and prioritize strategies with the highest impact.
How do you integrate market access strategy with clinical and launch planning?
Our work ensures alignment between pricing, evidence generation, and commercial planning. By coordinating with clinical teams and launch readiness efforts, we help clients translate strategic decisions into actionable adoption and reimbursement outcomes.
Through collaboration with Policy Reporter and Valeris teams, we align access strategy with real-world policy and reimbursement considerations, helping clients anticipate how clinical evidence will translate into coverage and uptake.
How does Triangle Insights Group support long-term value and sustainability for a product?
We evaluate product positioning, pricing, and access throughout the lifecycle to maintain value in the market. Our ongoing insights help clients anticipate competitive pressures, payer expectations, and evolving evidence requirements, enabling proactive, data-driven decisions rather than reactive adjustments.
From launch through loss of exclusivity, we partner with clients to continuously refine strategy, which includes optimizing gross-to-net performance, identifying access opportunities, and adapting to shifts in policy, competition, and patient needs. This lifecycle approach ensures products remain competitive, accessible, and financially sustainable over time.
By leveraging longitudinal policy and reimbursement insights from Policy Reporter, we help clients stay ahead of regulatory changes and evolving access dynamics—ensuring sustained competitiveness over time.